Recombinant Human Tnni3 Protein，His

Tnni3, or troponin I type 3, is a crucial regulatory protein involved in the contraction of cardiac and skeletal muscles. It is part of the troponin complex, which also includes troponin C and troponin T. The primary function of Tnni3 is to bind calcium ions and convey the signal necessary for muscle contraction in response to excitation. Abnormalities in Tnni3 expression or mutations in the gene encoding this protein can lead to various cardiovascular diseases, including hypertrophic cardiomyopathy and dilated cardiomyopathy, making it a significant focus of research. Additionally, Tnni3 serves as a marker for myocardial injury, and its presence in the bloodstream is used to diagnose heart attacks. Consequently, recombinant Tnni3 protein is being studied both for its role in understanding muscle physiology and pathology and for its potential use in therapeutic applications. Research on Tnni3 reconstitution and its interaction with other components of the contractile apparatus aims to elucidate the molecular mechanisms underlying muscle contraction and regulation, offering insights into potential interventions for heart diseases. The generation of recombinant Tnni3 also facilitates the study of the protein's biochemical properties and structural characteristics, allowing researchers to design drugs or therapies that specifically target its pathways, ultimately improving clinical outcomes for patients with cardiac dysfunction.